Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7250022rdf:typepubmed:Citationlld:pubmed
pubmed-article:7250022lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:7250022lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:7250022lifeskim:mentionsumls-concept:C0029254lld:lifeskim
pubmed-article:7250022lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7250022lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:7250022lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:7250022lifeskim:mentionsumls-concept:C0702039lld:lifeskim
pubmed-article:7250022pubmed:issue2lld:pubmed
pubmed-article:7250022pubmed:dateCreated1981-9-15lld:pubmed
pubmed-article:7250022pubmed:abstractTextThe authors found that the phosphororganic pesticide neguvon in a dose of 200 mg/kg of body weight diminished the content of dopamine in the striatum of white rats. This effect was increased after daily administration of the same dose for a period of 5 days. The reactivator of cholinesterase TMB-4 and H-choline blocker tropacine prevented this effect. They discussed the connection between the changes in the content of dopamine and modulating role of presynaptic choline receptors of H- and M- types in the dopaminergic terminals of the striatum.lld:pubmed
pubmed-article:7250022pubmed:languagebullld:pubmed
pubmed-article:7250022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:citationSubsetIMlld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7250022pubmed:statusMEDLINElld:pubmed
pubmed-article:7250022pubmed:issn0367-0643lld:pubmed
pubmed-article:7250022pubmed:authorpubmed-author:UzunovPPlld:pubmed
pubmed-article:7250022pubmed:authorpubmed-author:PanovaIIlld:pubmed
pubmed-article:7250022pubmed:authorpubmed-author:DishovskiKKlld:pubmed
pubmed-article:7250022pubmed:issnTypePrintlld:pubmed
pubmed-article:7250022pubmed:volume20lld:pubmed
pubmed-article:7250022pubmed:ownerNLMlld:pubmed
pubmed-article:7250022pubmed:authorsCompleteYlld:pubmed
pubmed-article:7250022pubmed:pagination62-6lld:pubmed
pubmed-article:7250022pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:meshHeadingpubmed-meshheading:7250022-...lld:pubmed
pubmed-article:7250022pubmed:year1981lld:pubmed
pubmed-article:7250022pubmed:articleTitle[Effect of the organophosphorus compound neguvon on the dopamine content in the rat brain].lld:pubmed
pubmed-article:7250022pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7250022pubmed:publicationTypeEnglish Abstractlld:pubmed